methenamine hippurate has been researched along with cefotaxime in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Friis-Møller, A; Hvidt, V; Jensen, SK; Korner, B; Olsen, JH | 1 |
1 review(s) available for methenamine hippurate and cefotaxime
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for methenamine hippurate and cefotaxime
Article | Year |
---|---|
Cefotaxime for prevention of infectious complications in bacteriuric men undergoing transurethral prostatic resection. A controlled comparison with methenamine.
Topics: Aged; Cefotaxime; Clinical Trials as Topic; Hippurates; Humans; Male; Methenamine; Middle Aged; Postoperative Complications; Premedication; Prostatectomy; Prostatic Hyperplasia; Random Allocation; Sepsis; Urethra; Urinary Tract Infections | 1983 |